Myomo Inc (MYO)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
CEO:
Employees:
45
ONE BROADWAY, 14TH FLOOR, CAMBRIDGE, MA 02142
617-996-9058

N/A

Data derived from most recent annual or quarterly report
Market Cap 13.131 Million Shares Outstanding6.875 Million Avg 30-day Volume 98.483 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.97
Price to Revenue1.7037 Debt to Equity0.0 EBITDA-9.678 Million
Price to Book Value2.0371 Operating Margin-65.4643 Enterprise Value13.075 Million
Current Ratio3.569 EPS Growth0.237 Quick Ratio3.146
1 Yr BETA 0.9514 52-week High/Low 14.35 / 1.61 Profit Margin-66.4582
Operating Cash Flow Growth-12.1487 Altman Z-Score-3.414 Free Cash Flow to Firm -8.084 Million
View SEC Filings from MYO instead.

View recent insider trading info

Myomo Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding MYO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MYO BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2022-06-16 by KOVELMAN HARRY
  • 4: filed on 2022-06-16 by HENRY DAVID A
  • 4: filed on 2022-06-16 by MITCHELL MICAH
  • 4: filed on 2022-06-10 by MITCHELL MICAH
  • 4: filed on 2022-06-10 by KOVELMAN HARRY
  • 4: filed on 2022-06-10 by HENRY DAVID A
  • 4: filed on 2022-06-09 by GUDONIS PAUL R
  • 4: filed on 2022-06-03 by KOVELMAN HARRY
  • 4: filed on 2022-05-24 by MITCHELL MICAH
  • 4: filed on 2022-05-24 by KOVELMAN HARRY

    • Events (8k)

  • 8-K: filed on 2022-06-10:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-05-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-01-10:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-01-05:
    Item 1.01: Entry into a Material Definitive Agreement
  • 8-K: filed on 2021-12-16:
    Item 8.01: Other Events
  • 8-K: filed on 2021-11-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-10-15:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-10-05:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-08-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    HENRY DAVID A CHIEF FINANCIAL OFFICER

    • Officer
    		 77,604 2022-06-13 4

    MITCHELL MICAH CHIEF COMMERICAL OFFICER

    • Officer
    		 49,431 2022-06-13 4

    KOVELMAN HARRY CHIEF MEDICAL OFFICER

    • Officer
    		 51,470 2022-06-13 11

    GUDONIS PAUL R CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 175,320 2022-06-08 5

    CROWLEY THOMAS ALOYSIUS JR.

    • Director
    		 39,873 2021-11-02 1

    CONNEIGHTON CLIFF CHIEF MARKETING OFFICER

    • Officer
    		 17,738 2021-06-11 0

    KIRK THOMAS F

    • Director
    		 26,180 2021-06-09 0

    MORRIS MILTON MAYO

    • Director
    		 0 2021-06-09 0

    KNAPP AMY K.

    • Director
    		 19,623 2021-06-09 0

    NAFT JONATHAN VP, GENERAL MANAGER

    • Officer
    		 22,298 2020-07-01 0

    GREEN BRANDON M CHIEF MEDICAL OFFICER

    • Officer
    		 1,664 2020-06-05 0

    SANGHI STEVE

    • Director
    		 570,621 2019-10-11 0

    GOLDWASSER RALPH A CHIEF FINANCIAL OFFICER

    • Officer
    		 78,619 2019-01-23 0

    MENDELSOHN DAVIE VP, SALES

    • Officer
    		 36,099 2019-01-23 0

    MGC VENTURE PARTNERS 2013, L.P.

    • FORMER 10% OWNER
    		 No longer subject to file 2017-12-31 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    MITCHELL MICAH - Officer CHIEF COMMERICAL OFFICER

    		2022-06-16 09:18:47 -0400 2022-06-13 F 1,846 $1.79 d 49,431 direct -0.5714 9.1429 9.1429 6 -0.5714 2

    KOVELMAN HARRY - Officer CHIEF MEDICAL OFFICER

    		2022-06-16 09:20:48 -0400 2022-06-13 F 484 $1.83 d 51,470 direct -0.5714 9.1429 9.1429 6 -0.5714 2

    HENRY DAVID A - Officer CHIEF FINANCIAL OFFICER

    		2022-06-16 09:19:33 -0400 2022-06-13 F 4,417 $1.80 d 77,604 direct -0.5714 9.1429 9.1429 6 -0.5714 2

    GUDONIS PAUL R - Director - Officer CHIEF EXECUTIVE OFFICER

    		2022-06-09 20:43:44 -0400 2022-06-08 A 75,000 a 175,320 direct -10.7232 -13.217 0.0 1 -14.7132 3

    HENRY DAVID A - Officer CHIEF FINANCIAL OFFICER

    		2022-06-10 16:41:54 -0400 2022-06-08 A 41,500 a 82,021 direct -4.4693 2.2346 2.2346 6 -4.4693 2

    KOVELMAN HARRY - Officer CHIEF MEDICAL OFFICER

    		2022-06-10 16:49:28 -0400 2022-06-08 A 28,000 a 51,954 direct -4.4693 2.2346 2.2346 6 -4.4693 2

    MITCHELL MICAH - Officer CHIEF COMMERICAL OFFICER

    		2022-06-10 16:59:45 -0400 2022-06-08 A 28,000 a 51,277 direct -4.4693 2.2346 2.2346 6 -4.4693 2

    KOVELMAN HARRY - Officer CHIEF MEDICAL OFFICER

    		2022-06-03 19:20:50 -0400 2022-06-03 F 138 $2.31 d 23,954 direct 6.7961 -13.1068 8.2524 3 -13.1068 6

    HENRY DAVID A - Officer CHIEF FINANCIAL OFFICER

    		2022-05-24 17:54:38 -0400 2022-05-24 F 3,394 $2.06 d 40,521 direct 4.902 8.3333 9.8039 4 0.0 1

    KOVELMAN HARRY - Officer CHIEF MEDICAL OFFICER

    		2022-05-24 18:15:18 -0400 2022-05-24 F 2,849 $2.06 d 24,092 direct 4.902 8.3333 9.8039 4 0.0 1

    GUDONIS PAUL R - Director - Officer CHIEF EXECUTIVE OFFICER

    		2022-05-24 16:59:53 -0400 2022-05-20 A 8,302 a 100,320 direct 4.902 8.3333 9.8039 4 0.0 1

    HENRY DAVID A - Officer CHIEF FINANCIAL OFFICER

    		2022-05-24 17:54:38 -0400 2022-05-20 A 8,297 a 43,915 direct 4.902 8.3333 9.8039 4 0.0 1

    KOVELMAN HARRY - Officer CHIEF MEDICAL OFFICER

    		2022-05-24 18:15:18 -0400 2022-05-20 A 6,987 a 26,941 direct 4.902 8.3333 9.8039 4 0.0 1

    MITCHELL MICAH - Officer CHIEF COMMERICAL OFFICER

    		2022-05-24 18:16:53 -0400 2022-05-20 A 7,424 a 23,277 direct 4.902 8.3333 9.8039 4 0.0 1

    KOVELMAN HARRY - Officer CHIEF MEDICAL OFFICER

    		2022-05-03 16:27:49 -0400 2022-05-03 F 134 $3.03 d 19,954 direct -4.4674 -16.8385 -39.8625 0.0 1 -41.2371 29

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    MYOMO INC MYO 2022-06-24 22:15:03 UTC -11.9794 13.5494 100000
    MYOMO INC MYO 2022-06-24 21:45:03 UTC -11.9794 13.5494 100000
    MYOMO INC MYO 2022-06-24 21:15:04 UTC -11.9794 13.5494 100000
    MYOMO INC MYO 2022-06-24 20:45:03 UTC -11.9794 13.5494 100000
    MYOMO INC MYO 2022-06-24 20:15:03 UTC -11.9794 13.5494 100000
    MYOMO INC MYO 2022-06-24 19:45:03 UTC -11.9794 13.5494 100000
    MYOMO INC MYO 2022-06-24 19:15:03 UTC -11.9794 13.5494 100000
    MYOMO INC MYO 2022-06-24 18:45:03 UTC -11.8834 13.4534 100000
    MYOMO INC MYO 2022-06-24 18:15:04 UTC -11.8834 13.4534 100000
    MYOMO INC MYO 2022-06-24 17:45:03 UTC -11.8834 13.4534 100000
    MYOMO INC MYO 2022-06-24 17:15:03 UTC -11.8834 13.4534 100000
    MYOMO INC MYO 2022-06-24 16:45:03 UTC -11.8834 13.4534 100000
    MYOMO INC MYO 2022-06-24 16:15:03 UTC -11.8834 13.4534 100000
    MYOMO INC MYO 2022-06-24 15:45:03 UTC -11.8834 13.4534 100000
    MYOMO INC MYO 2022-06-24 15:15:03 UTC -11.8834 13.4534 85000
    MYOMO INC MYO 2022-06-24 14:45:03 UTC -12.64 14.21 85000
    MYOMO INC MYO 2022-06-24 14:15:03 UTC -12.64 14.21 85000
    MYOMO INC MYO 2022-06-24 13:45:03 UTC -12.64 14.21 85000
    MYOMO INC MYO 2022-06-24 13:15:03 UTC -12.64 14.21 85000
    MYOMO INC MYO 2022-06-24 12:45:03 UTC -12.64 14.21 85000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    Elevate your investments